149 related articles for article (PubMed ID: 11821722)
21. Irbesartan substitution for valsartan or losartan in treating hypertension.
Graham MR; Allcock NM
Ann Pharmacother; 2002 Dec; 36(12):1840-4. PubMed ID: 12452741
[TBL] [Abstract][Full Text] [Related]
22. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
Smith DH; Dubiel R; Jones M
Am J Cardiovasc Drugs; 2005; 5(1):41-50. PubMed ID: 15631537
[TBL] [Abstract][Full Text] [Related]
23. Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients.
Hamada T; Mizuta E; Kondo T; Hirai M; Yamada K; Kato M; Shigemasa C; Yamamoto Y; Ninomiya H; Igawa O; Hisatome I
Arzneimittelforschung; 2010; 60(2):71-5. PubMed ID: 20329654
[TBL] [Abstract][Full Text] [Related]
24. The value of irbesartan in the management of hypertension.
Bramlage P; Durand-Zaleski I; Desai N; Pirk O; Hacker C
Expert Opin Pharmacother; 2009 Aug; 10(11):1817-31. PubMed ID: 19601700
[TBL] [Abstract][Full Text] [Related]
25. Headache, hypertension, and irbesartan therapy.
Benseñor IM; Lotufo PA
Arch Intern Med; 2001 Mar; 161(5):775-6. PubMed ID: 11231724
[No Abstract] [Full Text] [Related]
26. Anaemia in dialysis patients as a side-effect of sartanes.
Schwarzbeck A; Wittenmeier KW; Hällfritzsch U
Lancet; 1998 Jul; 352(9124):286. PubMed ID: 9690412
[No Abstract] [Full Text] [Related]
27. [Irbesartan in hypertensive non-diabetic advanced chronic kidney disease. Comparative study with ACEI].
Coronel F; Cigarrán S; García-Mena M; Herrero JA; Calvo N; Pérez-Flores I
Nefrologia; 2008; 28(1):56-60. PubMed ID: 18336132
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden.
Ekman M; Bienfait-Beuzon C; Jackson J
J Hum Hypertens; 2008 Dec; 22(12):845-55. PubMed ID: 18633426
[TBL] [Abstract][Full Text] [Related]
29. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade?
Brunner HR
J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462
[No Abstract] [Full Text] [Related]
30. [Other antihyperuricemic agents].
Ogino K; Igawa O; Hisatome I
Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
[TBL] [Abstract][Full Text] [Related]
31. A population-based European cohort study of persistence in newly diagnosed hypertensive patients.
Hasford J; Mimran A; Simons WR
J Hum Hypertens; 2002 Aug; 16(8):569-75. PubMed ID: 12149663
[TBL] [Abstract][Full Text] [Related]
32. Effect of Antihypertensive Drugs on Uric Acid Metabolism in Patients with Hypertension: Cross-Sectional Cohort Study.
Ueno S; Hamada T; Taniguchi S; Ohtani N; Miyazaki S; Mizuta E; Ohtahara A; Ogino K; Yoshida A; Kuwabara M; Yoshida K; Ninomiya H; Kotake H; Taufiq F; Yamamoto K; Hisatome I
Drug Res (Stuttg); 2016 Dec; 66(12):628-632. PubMed ID: 27643410
[No Abstract] [Full Text] [Related]
33. [Irbesartan--current trends in the management of hypertension].
Dtsch Med Wochenschr; 1998 Feb; 123(8 Suppl):1-4. PubMed ID: 9531920
[No Abstract] [Full Text] [Related]
34. Losartan--a new antihypertensive.
Drug Ther Bull; 1995 Oct; 33(10):73-4. PubMed ID: 7493558
[No Abstract] [Full Text] [Related]
35. Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension.
Kochar M; Guthrie R; Triscari J; Kassler-Taub K; Reeves RA
Am J Hypertens; 1999 Aug; 12(8 Pt 1):797-805. PubMed ID: 10480473
[TBL] [Abstract][Full Text] [Related]
36. A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertension.
Andersson OK; Neldam S
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S63-4. PubMed ID: 9331011
[No Abstract] [Full Text] [Related]
37. [Health economic aspects of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension].
Schute LL
Dtsch Med Wochenschr; 2004 Jun; 129(25-26):1448; author reply 1448. PubMed ID: 15213879
[No Abstract] [Full Text] [Related]
38. [Losartan (LORZAAR) and Losartan/hydrochlorothiazide (LORZAAR-PLUS)--their value in hypertension therapy. Symposium on the occasion of the 103rd Session of the German Society. Wiesbaden, 7 April 1997].
Dtsch Med Wochenschr; 1997 Sep; 122(36 Suppl Losartan):1-4. PubMed ID: 9330577
[No Abstract] [Full Text] [Related]
39. [Irbesartan: a new possibility in the treatment of hypertension].
Rapi J
Orv Hetil; 2002 May; 143(21):1187-92. PubMed ID: 12073539
[TBL] [Abstract][Full Text] [Related]
40. AT1-receptor antagonism in hypertension: what has been learned with irbesartan?
Waeber B; Burnier M
Expert Rev Cardiovasc Ther; 2003 May; 1(1):23-33. PubMed ID: 15030294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
